Cargando…
An analysis of ranibizumab treatment and visual outcomes in real-world settings: the UNCOVER study
PURPOSE: To describe intravitreal ranibizumab treatment frequency, clinical monitoring, and visual outcomes (including mean central retinal thickness [CRT] and visual acuity [VA] changes from baseline) in neovascular age-related macular degeneration (nAMD) in real-world settings across three ranibiz...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5911274/ https://www.ncbi.nlm.nih.gov/pubmed/29502232 http://dx.doi.org/10.1007/s00417-017-3890-8 |